Insights into the biology of primary central nervous system lymphoma.

Maciej Mrugala, James L. Rubenstein, Maurilio Ponzoni, Tracy T. Batchelor

Research output: Contribution to journalReview article

18 Scopus citations

Abstract

Primary central nervous system lymphoma (PCNSL) is a rare variant of non-Hodgkin lymphoma that is confined to the central nervous system. Biologic studies of PCNSL are challenging to conduct because the disease is rare and available tissue material is sparse. However, in recent years there has been progress in the understanding of PCNSL biology, largely as the result of multicenter studies using modern molecular techniques. Recent studies may improve insight into the pathogenesis of PCNSL and increase the chances of identifying prognostic factors and novel therapeutic targets. This review discusses recent advances in PCNSL biology, including immunologic and genetic risk factors, and focuses on the molecular alterations important in central nervous system lymphomagenesis.

Original languageEnglish (US)
Pages (from-to)73-80
Number of pages8
JournalCurrent oncology reports
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2009
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Oncology

Cite this